Skip to main content
. 2022 Jun 3;18(2):e169–e178. doi: 10.4244/EIJ-D-21-00862

Table 2. Periprocedural findings.

Total
n=140
Residual TR ≥3+
n=43
Residual TR <3+
n=97
p-value
Device type, n (%) MitraClip/TriClip</p> 111 (79.3) 30 (69.8) 81 (83.5) 0.06
PASCAL 29 (20.7) 13 (30.2) 16 (17.5)
Simultaneous TMVR, n (%) 18 (12.9) 3 (7.0) 15 (15.5) 0.17
Implant success, n (%) 131 (93.6) 34 (79.1) 97 (100.0) <0.001
Number of clips, n (%) 0 9 (6.4) 9 (20.9) 0 (0.0) <0.001
1 35 (25.0) 7 (16.3) 28 (28.9)
2 72 (51.4) 17 (39.5) 55 (56.7)
3 21 (15.0) 9 (20.9) 12 (12.4)
4 3 (2.1) 1 (2.3) 2 (2.1)
Mean (if implanted) 1.9±0.7 2.1±0.8 1.9±0.7 0.09
Implantation site of devices, n (%)* Anteroseptal coaptation line 202 (80.2) 53 (73.6) 149 (82.8) 0.31
Posteroseptal coaptation line 47 (18.7) 16 (22.2) 31 (17.2)
Anteroposterior coaptation line 3 (1.2) 3 (4.2) 0 (0.0)
Mean tricuspid valve gradient, mmHg 2.6±1.5 2.9±1.4 2.4±1.5 0.08
Post-procedural TR grade, n (%) 0 or 1+ 24 (17.1) 0 (0.0) 24 (24.7) <0.001
2+ 73 (52.1) 0 (0.0) 73 (75.3)
3+ 38 (27.1) 38 (88.4) 0 (0.0)
4+ 3 (2.1) 3 (7.0) 0 (0.0)
5+ 2 (1.4) 2 (4.7) 0 (0.0)
Post-procedural vena contracta (mm) 6.0 [4.1. 8.0] 10.0 [8.1, 12.1] 5.0 [3.9, 6.0] <0.001
Acute procedural success, n (%) 126 (90.0) 29 (67.4) 97 (100.0) <0.001
Values are n (%) or mean±SD. *Numbers and percentages indicate number and percentage of clips implanted. TMVR: transcatheter mitral valve repair; TR: tricuspid regurgitation